#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Andersen-Tawil syndrome Leiomyosarcoma Stargardt's disease Rhabdomyosarcoma Hypoxic-ischaemic encephalopathy Peritoneal mesothelioma malignant Hairy cell leukaemia recurrent Pleomorphic liposarcoma Cholestatic pruritus Acquired haemophilia Ovarian cancer stage III Spinal cord injury cervical Immune-mediated myasthenia gravis Lymphangiosarcoma Non-Hodgkin's lymphoma refractory More trials…

    Learn about Rare Diseases

    Vascular malformation – Basic Information Pleomorphic leiomyosarcoma – Treatment SAPHO syndrome – Trials in Disease Haemophilia B without inhibitors – Life with Disease Tuberous sclerosis complex – Basic Information Choroid melanoma – Diagnostics Hereditary neuropathic amyloidosis – Basic Information Synovial sarcoma – Basic Information Myxofibrosarcoma – Treatment Richter’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Erythromycin Lactobionate GT-002 ETX-19477 Olopatadine Hydrochloride Sevoflurane Irinotecan Hydrochloride Insulin Aspart Rapcabtagene Autoleucel SAR443820 Tafluprost VIPOGLANSTAT Piperacillin Sodium Op-1250 Pirfenidone Guanabenz Acetate Metolazone Afamitresgene Autoleucel RNMB3 Bemnifosbuvir Hemisulfate LVT-001 More therapies…

    Learn about Your Condition

    Glomerulonephritis membranous Breast cancer stage IV Chronic spontaneous urticaria Hepatocellular carcinoma Nodal osteoarthritis Congenital pseudarthrosis Arthritis infective Bronchopulmonary dysplasia Diabetic gastroparesis Schizoaffective disorder Influenza Hepatobiliary cancer B-cell lymphoma refractory Breast cancer stage II Antisynthetase syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study of Batoclimab for Treating Patients with Active Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Batoclimab
    Belgium Germany Hungary Latvia Slovakia Spain

  • Study on the Safety and Tolerability of Teprotumumab for Patients with Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Teprotumumab
    France Germany Italy Spain

  • Study on Allogenic Stem Cells and Amniotic Membrane for Patients with Advanced Corneal Ulcers Unresponsive to Standard Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Ulcerative keratitis
    Investigated Drugs:
    • Allogenic Corneal-Derived Adult Keratocytes, Ex-Vivo Expanded
    • Allogenic Sclerocorneal Limbus Stem-Derived Adult Limbal Cells, Ex-Vivo Expanded
    • Amniotic Membrane, Human
    Spain

  • Study on the Safety and Efficacy of Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Linsitinib
    Italy Spain

  • Study on Batoclimab for Patients with Thyroid Eye Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Batoclimab
    Belgium Hungary Italy Latvia Poland Slovakia +1

  • Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Belgium France Germany Italy Spain
Previous Page
1 … 29 30 31 32 33 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!